Pompe Disease Market Set for Expansion During the Forecast Period (2026-2036) as Growth is Fueled by Next-Generation ERTs, Newborn Screening, and Pipeline Innovation | DelveInsight

Summary

Market analysis forecasts significant expansion in the Pompe disease market from 2026-2036 driven by next-generation enzyme replacement therapies (ERTs) and pipeline innovations from multiple companies including Shionogi/Maze, Astellas, AskBio/Bayer, and Denali Therapeutics.